Detalles de la búsqueda
1.
Outcomes of younger patients with mantle-cell lymphoma experiencing late relapse (>24 months): the LATE-POD study.
Blood
; 2024 05 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38754055
2.
Lenalidomide plus rituximab for the initial treatment of frail older patients with DLBCL: the FIL_ReRi phase 2 study.
Blood
; 142(17): 1438-1447, 2023 10 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-37418685
3.
Secondary primary malignancies after CD-19 directed CAR-T-cell therapy in lymphomas: A report from the Italian CART-SIE study.
Br J Haematol
; 2024 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38877876
4.
A rescue approach in refractory diffuse large B-cell lymphoma with obinutuzumab-redirected cytokine-induced killer cells: a first-in-human case report.
Haematologica
; 2024 May 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38721751
5.
SARS-CoV-2 infection and vaccination in patients with hairy-cell leukaemia.
Br J Haematol
; 201(3): 411-416, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36541031
6.
SARS-CoV-2 infection in patients with chronic lymphocytic leukemia: The Italian Hematology Alliance on COVID-19 cohort.
Hematol Oncol
; 41(1): 128-138, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36265128
7.
Impact of severe acute respiratory syndrome coronavirus-2 infection on the outcome of primary central nervous system lymphoma treatment: A study of the International PCNSL Collaborative Group.
Br J Haematol
; 199(4): 507-519, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35945164
8.
Obinutuzumab does not improve complete methabolic response but does not compromise mobilization or engraftment of autologous peripheral blood stem cells in diffuse large B cell lymphoma: Results from a fondazione italiana linfomi prospective phase II study (the GIOTTO study).
Hematol Oncol
; 40(4): 609-616, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-35612350
9.
Invasive aspergillosis in relapsed/refractory acute myeloid leukaemia patients: Results from SEIFEM 2016-B survey.
Mycoses
; 65(2): 171-177, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34695256
10.
Infections in patients with lymphoproliferative diseases treated with targeted agents: SEIFEM multicentric retrospective study.
Br J Haematol
; 193(2): 316-324, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33058237
11.
A serum-free protocol for the ex vivo expansion of Cytokine-Induced Killer cells using gas-permeable static culture flasks.
Cytotherapy
; 22(9): 511-518, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32631696
12.
Direct-Acting Antivirals in Hepatitis C Virus-Associated Diffuse Large B-cell Lymphomas.
Oncologist
; 24(8): e720-e729, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30552159
13.
A Comparison of the Conditioning Regimens BEAM and FEAM for Autologous Hematopoietic Stem Cell Transplantation in Lymphoma: An Observational Study on 1038 Patients From Fondazione Italiana Linfomi.
Biol Blood Marrow Transplant
; 24(9): 1814-1822, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29857196
14.
IDH2R172 mutation in angioimmunoblastic T-cell lymphoma: A retrospective multicenter case series.
Eur J Haematol
; 110(2): 217-220, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36264618
15.
Prospective multicenter study on infectious complications and clinical outcome of 230 unfit acute myeloid leukemia patients receiving first-line therapy with hypomethylating agents alone or in combination with Venetoclax.
Am J Hematol
; 98(4): E80-E83, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36651870
16.
Hepatitis C virus positive diffuse large B-cell lymphomas have distinct molecular features and lack BCL2 translocations.
Br J Cancer
; 117(11): 1685-1688, 2017 Nov 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-28949959
17.
Management of chronic lymphocytic leukemia in Italy during a one year of the COVID-19 pandemic and at the start of the vaccination program. A Campus CLL report.
Hematol Oncol
; 39(4): 570-574, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34258787
18.
Axicabtagene ciloleucel treatment is more effective in primary mediastinal large B-cell lymphomas than in diffuse large B-cell lymphomas: the Italian CART-SIE study.
Leukemia
; 38(5): 1107-1114, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38459167
19.
The mortality of COVID-19 in CML patients from 2020 until 2022: results from the EPICOVIDEHA survey.
Leuk Lymphoma
; 65(2): 199-208, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37966980
20.
The host genetic background of DNA repair mechanisms is an independent predictor of survival in diffuse large B-cell lymphoma.
Blood
; 117(8): 2405-13, 2011 Feb 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-21156845